Pharmaceutical Benefits Scheme (PBS)

The official online source for information on your PBS.

This web site contains information on the Pharmaceutical Benefits Scheme including details of the medicines subsidised by the Australian Government as well as information for consumers, carers, health professionals and the pharmaceutical industry. The PBS is part of Australia's broader National Medicines Policy (NMP).

 

PBS News Updates

Australian Statistics on Medicines 2011

17 April 2014

The Australian Statistics on Medicines 2011 is now available.

 

Summary of 1 August 2014 price reductions for the 2014 Supplementary Cycle A by drug / manner of administration / percentage reduction

17 April 2014

The summary of 1 August 2014 price reductions for the 2014 Supplementary Cycle A has now been published on the ‘Price Disclosure (EAPD)’ page of this web site.

 

Tropical Cyclone Ita

11 April 2014

The Department of Health has introduced temporary arrangements to assist residents and pharmacists in areas in Far North Queensland being impacted by Tropical Cyclone Ita.  The information page includes details on how pharmacists can manage additional supplies for residents whose medicine and prescriptions have been lost in the current emergency. Please use the contact numbers in the information page for further information about medicine issues. 

PBS Website Update – 1 April 2014

1 April 2014

The Schedule of Pharmaceutical Benefits was updated on 1 April 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Confirmation of 1 April 2014 Price Disclosure Prices and New Price Disclosure Fact Sheet

12 March 2014

Confirmation of 1 April 2014 new prices resulting from 2014 Main Cycle of EAPD have now been published in the EAPD section of this website.

A new Price Disclosure Fact Sheet: Differences between IMS Profits Data and Disclosed Data has been published to improve responsible persons' understanding of differences between price disclosure outcomes and any outcomes that may be estimated using IMS data.

 

Streamlined PBS pricing processes to improve access to medicines

7 March 2014

From 1 April 2014, the Government will implement a new streamlined process to reduce the time taken to list medicines on the Pharmaceutical Benefits Scheme (PBS) and improve access to medicines.  A key component of this measure will be the cessation of the operations of the Pharmaceutical Benefits Pricing Authority (PBPA).

The measure will further streamline PBS listing processes by allowing agreement on price to be reached in shorter timeframes following a positive recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC).

As currently, the final decision on the price of a medicine will be made by the Minister (or delegate).  However the streamlined process will allow important new medicines to be listed on the PBS at least four weeks earlier than is presently possible.  At the same time, sponsors will benefit from having additional time, to the end of week five after the meeting of the PBAC, in which to finalise pricing submissions following a positive PBAC recommendation.

Arrangements following cessation of the PBPA will require sponsors of submissions to the PBAC to provide cost of goods information at the time of making the submission but there will be a transition period for these arrangements to assist industry.  There will be no change to the current application processes for sponsors seeking price increases for currently subsidised medicines. 

The PBS website will be updated to reflect the new arrangements. The department will also be in contact with member organisations to facilitate this information being provided to all pharmaceutical companies to ensure a smooth transition to the new expedited listing arrangements.

Enquiries can be directed to the Pricing Section.

 

PBS Website Update – 1 March 2014

1 March 2014

The Schedule of Pharmaceutical Benefits was updated on 1 March 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Additional information - linagliptin with metformin (Trajentamet®) and saxagliptin with metformin (Kombiglyze®)

These products will have the same restriction as the recently-listed alogliptin with metformin (Nesina Met). They will be available for use as as an option in diabetes mellitus type 2 where initial treatment with metformin alone has not been sufficient to control a patient's diabetes.

 

PBS Website Update – 1 February 2014

1 February 2014

The Schedule of Pharmaceutical Benefits was updated on 1 February 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

PBS mobile website

24 January 2014

A smart phone and tablet version of the PBS website is now available. Users of mobile devices now have the option to view either the standard or mobile versions of the PBS Website. The mobile version can be accessed directly via m.pbs.gov.au. Any feedback or questions regarding the mobile version can be emailed to the PBS Webmaster.

 

WA Bushfire Emergency - temporary PBS arrangements for fire-affected zones

17 January 2014

The Department of Health has introduced temporary arrangements to assist residents and pharmacists in fire-affected areas in WA to maintain medicine supplies.

The document: Advice for approved pharmacists supplying PBS medicines to patients in areas affected by bushfire in WA includes details on how pharmacists can manage additional supplies for residents whose medicine and prescriptions have been lost in the current bushfire emergency.

Please use the contact numbers in the information document for further information about bushfire-related medicine issues.

 

PBAC Guidelines website

16 January 2014

The Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines v4.4 are now available at www.pbac.pbs.gov.au.

 

2014 PBS co-payment and safety net amounts

3 January 2014

In line with changes in the consumer price index, the PBS co-payment and safety net amounts have been revised.  Therefore, the following changes are effective on 1 January 2014:

  • the general patient co-payment will increase from $36.10 to $36.90;
  • the concessional co-payment will increase from $5.90 to $6.00;
  • the general safety net threshold will increase from $1,390.60 to $1,421.20 and
  • the concessional safety net will increase from $354.00 to $360.00.

 

PBS Website Update – 1 January 2014

1 January 2014

The Schedule of Pharmaceutical Benefits was updated on 1 January 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Summary of 1 April 2014 price reductions for the 2014 Main Cycle by drug/ manner of administration/ percentage reduction

16 December 2013

The summary of 1 April 2014 price reductions for the 2014 main cycle has now been published on the Price Disclosure (EAPD) page.

 

Price Disclosure (Simplified Price Disclosure)

11 December 2013

A stakeholder information session regarding the implementation of Simplified Price Disclosure was held at the Department of Health on 6 December 2013.

The presentation and additional information is now available.

 

PBS Website Update – 1 December 2013

1 December 2013

The Schedule of Pharmaceutical Benefits was updated on 1 December 2013 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Updated Price Disclosure Guidelines

26 November 2013

An updated version of the Price Disclosure Arrangements Procedural and Operational Guidelines for Expanded and Accelerated Price Disclosure has been published. The updated Guidelines reflect changes made to the National Health (Pharmaceutical  Benefits) Regulations 1960 in April 2013. More information is available on the news page.

 

Advance notice of 1 December 2013 new prices resulting from 2013 Supplementary Cycle B of EAPD

4 November 2013

The new prices resulting from reductions as per 2013 Supplementary Cycle B have now been published in the EAPD section of this web site. These price disclosure related changes are being made available in advance of the effective date (1 December 2013), to assist companies.  The reductions come into effect under the National Health Act 1953 and have already been announced publicly on 20 August 2013.

 

PBS Website Update – 1 November 2013

1 November 2013

The Schedule of Pharmaceutical Benefits was updated on 1 November 2013 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

New listings for the PBS announced on 28 October 2013

28 October 2013

New and amended listings for the PBS have been announced. More information is available on the Minister for Health's website.

 

NSW Bushfire Emergency - temporary PBS arrangements for fire-affected zones

22 October 2013

The Department of Health has introduced temporary arrangements to assist residents and pharmacists in fire-affected areas in NSW to maintain medicine supplies.

The document: Advice for approved pharmacists supplying PBS medicines to patients in areas affected by bushfire in NSW includes details on how pharmacists can manage additional supplies for residents whose medicine and prescriptions have been lost in the current bushfire emergency.

Please use the contact numbers in the information document for further information about bushfire-related medicine issues.

 

Stakeholder Forum: Post-Market Review of PBS Medicines Used to Treat Asthma in Children

17 October 2013

A Stakeholder Forum for the Post-Market Review of PBS Medicines Used to Treat Asthma in Children will be held in Canberra on 18 November 2013. Invitees will include pharmaceutical sponsors of asthma medicines, peak bodies, and individuals (clinicians and consumers) who have provided submissions to the Review. More information is available on the Asthma in Children Review web page.

 

PBS Website Update – 1 October 2013

1 October 2013

The Schedule of Pharmaceutical Benefits was updated on 1 October 2013 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Agenda for the November 2013 PBAC meeting

26 September 2013

The Agenda for the November 2013 Pharmaceutical Benefit Advisory Committee (PBAC) meeting is now available.

Your comments are welcome whether you are a patient, carer, member of the public, health professional or member of a consumer interest group.

The company applying for subsidy under the Pharmaceutical Benefits Scheme has already provided the PBAC with detailed clinical and economic data in support of the application. You are welcome to provide comments, for consideration by the PBAC, from a personal or group perspective on the impact of the condition addressed in the application.

The Online Comments form and further information can be found on the Department of Health web site.

 

PBS Website Update – 1 September 2013

1 September 2013

The Schedule of Pharmaceutical Benefits was updated on 1 September 2013 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Post-Market Review of Products Used for Diabetes Management

26 August 2013

The public submissions from Stage Three of the Review focussing on medicines used in the management of type 2 diabetes have now been published. More information about the Review is available on the Diabetes Review web page.

 

Stakeholder Forum: Stages 2 and 3 of the Diabetes Post-Market Review

8 August 2013

A combined Stakeholder Forum for Stages 2 (Insulin Pumps) and 3 (Medicines) of the Diabetes Review will be held in Canberra on 12 September 2013. Invitees will include manufacturers of insulin pumps, pharmaceutical sponsors of diabetes medicines, peak bodies, and individuals (clinicians and consumers) who have provided submissions to the Review. More information is available on the Diabetes Review web page.

 

PBS Website Update – 1 August 2013

1 August 2013

The Schedule of Pharmaceutical Benefits was updated on 1 August 2013.

The following updates have also been made to the PBS Website:

 

Contact Us

Department of Health
Ph: 1800 020 613
pbs@health.gov.au

Department of Human Services
(administers the PBS)
General enquiries 132 290
pbs@humanservices.gov.au

Dept of Veterans’ Affairs
RPBS enquiries
Ph: 1800 552 580

Poisons Information Centres
Ph 131 126 (24hrs)

Medicines Information Centre
NPS Medicines Line (for consumers only)
Ph: 1300 633 424

Therapeutic Goods Administration
Report adverse drug reactions
Ph: 1800 044 114

Consumer level recalls only
Ph: 1800 020 512

Telephone Interpreter Service
Ph: 131 450 (24hrs)

more contacts